LARIMAR THERAPEUTICS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $9.9M | $131.6M | $32.4M |
| FY2017 | $27.3M | $105.5M | $40.8M |
| FY2018 | $28.5M | $121.8M | $49.3M |
| FY2019 | $5.9M | $5.2M | $1.0M |
| FY2020 | $15.0M | $104.7M | $68.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $9.9M | $131.6M | $32.4M |
| FY2017 | $27.3M | $105.5M | $40.8M |
| FY2018 | $28.5M | $121.8M | $49.3M |
| FY2019 | $5.9M | $5.2M | $1.0M |
| FY2020 | $15.0M | $104.7M | $68.1M |